CART infusion
2022/00272
Phase 2 other active
Quick answer
CART infusion for B-cell Lymphoma Refractory is a Phase 2 program (other) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- B-cell Lymphoma Refractory
- Phase
- Phase 2
- Modality
- other
- Status
- active